Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Folfirinox regimen

View Patient Information
A regimen consisting of fluorouracil, irinotecan, leucovorin and oxaliplatin that can be used for the treatment of pancreatic and colorectal cancers; occult primary, appendiceal and small bowel adenocarcinomas; well-differentiated grade 3 neuroendocrine tumors (NETs), and extrapulmonary poorly differentiated neuroendocrine carcinoma, large or small cell carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:fluorouracil with irinotecan hydrochloride, leucovorin calcium and oxaliplatin
fluorouracil-leucovorin-irinotecan-oxaliplatin regimen
fluorouracil/irinotecan/leucovorin calcium/oxaliplatin
FOLFIRINOX protocol
folinic acid/fluorouracil/irinotecan/oxaliplatin
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search